ArticleFrontiers in pharmacology2022

Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer.

Xujun Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.